Pharma Focus Asia

Enable Injections Enters into Strategic Partnership with Genentech, a Member of the Roche Group

Friday, August 23, 2019

Enable Injections, Inc. (Enable), a company developing and manufacturing investigational wearable infusion devices for combination products, today announced it has entered into a development agreement with Genentech, a member of the Roche Group. The enFuse™, under development by Enable, will enable patient-administered subcutaneous delivery of high-volume therapeutics.

This Enable and Genentech partnership includes the potential for multiple molecule development programs incorporating long-term manufacturing and supply arrangements.

The Enable enFuse is an on-body drug delivery platform with a drug transfer system compatible with standard syringes or vial container formats. The wearable enFuse platform is being developed for subcutaneous administration of large-volumes potentially ranging up to 50 mL. Designed for ease of use, the enFuse has the potential to provide patients and their caregivers an alternative delivery method for subcutaneous administration of parenteral therapies outside of a clinical setting.

"Enable Injections is pleased to partner with Genentech in its focus on delivering patient-focused solutions," said Michael D. Hooven, Enable Injections Founder, President and CEO. "With the enFuse paired to deliver selected subcutaneous therapeutics, it can potentially benefit patients worldwide."

magazine-slider-imageMFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopNitrosamine Advance Workshop 2024CPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024LogiPharma Asia 2024